Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Invested Capital (2021 - 2025)

Puma Biotechnology (PBYI) has disclosed Return on Invested Capital for 5 consecutive years, with 0.27% as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Return on Invested Capital fell 7.0% year-over-year to 0.27%, compared with a TTM value of 0.27% through Mar 2025, down 7.0%, and an annual FY2022 reading of 0.51%, up 7.0% over the prior year.
  • Return on Invested Capital was 0.27% for Q1 2025 at Puma Biotechnology, up from 0.04% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 1.18% in Q1 2023 and bottomed at 0.67% in Q3 2021.
  • Average Return on Invested Capital over 5 years is 0.32%, with a median of 0.3% recorded in 2024.
  • The sharpest move saw Return on Invested Capital surged 161bps in 2022, then tumbled -85bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.2% in 2021, then surged by 582bps to 0.94% in 2022, then tumbled by -45bps to 0.52% in 2023, then crashed by -92bps to 0.04% in 2024, then skyrocketed by 544bps to 0.27% in 2025.
  • Business Quant data shows Return on Invested Capital for PBYI at 0.27% in Q1 2025, 0.04% in Q3 2024, and 0.22% in Q2 2024.